Trials that use: P-values
New to this method? Read the tutorial →
10,701 results
- Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ketamine in Borderline Personality Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine in Borderline Personality Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395314).
- Ketamine Patient-Controlled Analgesia for Acute Pain: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Patient-Controlled Analgesia for Acute Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02062879).
- Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): Complete Statistical AnalysisIndependent statistical analysis of Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ketogenic Diet (KD) in Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Ketogenic Diet (KD) in Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255031).
- KetoPltAggIndependent statistical analysis of IV Ketorolac on Platelet Function Post-Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03805607).
- Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.: Complete Statistical AnalysisIndependent statistical analysis of Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KetPTSDIndependent statistical analysis of Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00749203).
- KEYNOTE-010Independent statistical analysis of KEYNOTE-010, including its randomized phase 2/3 design, overall survival, progression-free survival, response, safety, statistical methods, and interpretation.
- KEYNOTE-040Independent statistical analysis of KEYNOTE-040, a randomized phase 3 trial of pembrolizumab versus standard treatment for recurrent or metastatic head and neck squamous cell cancer, including overall survival, progression-free survival, response, statistical…
- KEYNOTE-054Independent statistical analysis of KEYNOTE-054, a randomized phase 3 trial of pembrolizumab versus placebo after complete resection of high-risk stage III melanoma, including recurrence-free survival, Cox modeling, confidence intervals, and statistical interpretation.
- KEYNOTE-189Independent statistical analysis of KEYNOTE-189 (NCT02578680), a randomized phase 3 trial evaluating pembrolizumab with pemetrexed-platinum chemotherapy in first-line metastatic nonsquamous non-small cell lung cancer.
- KEYNOTE-240Independent statistical analysis of KEYNOTE-240, a randomized phase 3 trial of pembrolizumab plus best supportive care versus placebo plus best supportive care in previously systemically treated advanced hepatocellular carcinoma.
- KEYNOTE-394Independent statistical analysis of KEYNOTE-394, a randomized phase 3 trial of pembrolizumab or placebo with best supportive care in Asian participants with previously treated advanced hepatocellular carcinoma.
- KEYNOTE-564Independent statistical analysis of KEYNOTE-564, a randomized phase 3 trial of pembrolizumab versus placebo in the adjuvant treatment of renal cell carcinoma after nephrectomy, including disease-free survival, trial design, statistical methodology, and…
- KEYNOTE-671Independent statistical analysis of KEYNOTE-671, a randomized phase 3 trial of pembrolizumab with platinum-doublet chemotherapy as neoadjuvant/adjuvant therapy for resectable stage II, IIIA, and resectable IIIB non-small cell lung cancer.
- KEYNOTE-782Independent statistical analysis of Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- KEYNOTE-A18Independent statistical analysis of KEYNOTE-A18 (NCT04221945), a randomized phase 3 trial of chemoradiotherapy with or without pembrolizumab in locally advanced cervical cancer, including primary time-to-event results, secondary endpoints, cLDA, stratified analysis, and…
- KHLADIndependent statistical analysis of Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00953576).
- KIIndependent statistical analysis of Electromyostimulation and Strength Walking for Knee Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02065518).
- Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS: Complete Statistical AnalysisIndependent statistical analysis of Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- KIDPROAMIndependent statistical analysis of Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- KINETICIndependent statistical analysis of Ketamine to Improve Recovery After Cesarean Delivery - Part 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04037085).
- KINGIndependent statistical analysis of Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- KIRMONOIndependent statistical analysis of Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- KIS-IVIndependent statistical analysis of Advancing Tobacco Use Treatment for African American Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02360631).
- KISSIndependent statistical analysis of Aripiprazole, Abilify Maintena Collaborative Clinical Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02472652).
- KIU!Independent statistical analysis of Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men: primary endpoint results, effect estimate with confidence interval,…
- KNOCOUT PEIndependent statistical analysis of An International Pulmonary Embolism Registry Using EKOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03426124).
- Kokkerelli Learning Street Effect Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Kokkerelli Learning Street Effect Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04190680).
- KOMETIndependent statistical analysis of Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- KontRASt-06Independent statistical analysis of Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1…
- KPL-301 for Subjects With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of KPL-301 for Subjects With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03827018).
- KRYSTAL-12Independent statistical analysis of KRYSTAL-12, the phase 3 randomized trial of adagrasib versus docetaxel in patients with advanced non-small cell lung cancer with a KRAS G12C mutation.
- ktpumpIndependent statistical analysis of Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00574405).
- L-arginine in Treatment as Usual in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of L-arginine in Treatment as Usual in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00718510).
- L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: Complete Statistical AnalysisIndependent statistical analysis of L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733407).
- L-ThyroxineIndependent statistical analysis of Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06660823).
- La ComunidadIndependent statistical analysis of Latinos Combating Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831921).
- Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114971).
- Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: Complete Statistical AnalysisIndependent statistical analysis of Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01844687).
- Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LABYRIndependent statistical analysis of Wayfinding Intervention in High-Fidelity Long-Term Memory: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04253587).
- LADIIIndependent statistical analysis of Labor and Delivery Implant Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02866643).
- LAL1610Independent statistical analysis of Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation: Complete Statistical AnalysisIndependent statistical analysis of Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Lamotrigine Bioequivalence: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Bioequivalence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01995825).
- Lamotrigine Extended-Release In Elderly Patients With Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Extended-Release In Elderly Patients With Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00516139).
- LAMPIndependent statistical analysis of Learning to Apply Mindfulness to Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04526158).